Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Effect of lipoic acid consumption on oxidative stress among multiple sclerosis patients: A randomized controlled clinical trial.
iPSC-derived neural precursors exert a neuroprotective role in immune-mediated demyelination via the secretion of LIF.
Modulation of nitric oxide synthase by arginase and methylated arginines during the acute phase of experimental multiple sclerosis.
Laquinimod suppress antigen presentation in relapsing-remitting multiple sclerosis: in-vitro high-throughput gene expression study.
Potassium-Retaining Diuretics: Amiloride
ALAIN01-Alemtuzumab in autoimmune inflammatory neurodegeneration: mechanisms of action and neuroprotective potential.
Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group.
Novel Immune Regulator Shows Promise as MS Therapy in Clinical Trials
Efficacy and safety of interferon beta-1b sc in older RRMS patients--a posthoc analysis of the BEYOND study.
Transcriptional response to interferon beta-1a treatment in patients with secondary progressive multiple sclerosis.
Effectiveness of Natalizumab in Patients with Highly Active Relapsing Remitting Multiple Sclerosis.
Laquinimod
Changes to anti-JCV antibody levels in a Swedish national MS cohort.
Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS.
Receptos Reports Positive Phase 2 Results for RPC1063 in Relapsing Multiple Sclerosis
The delta-subunit of the epithelial sodium channel (ENaC) enhances channel activity and alters proteolytic ENaC activation.
Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
Rituximab: Don't Count It Out as MS Treatment
Cyclophosphamide as second-line therapy in multiple sclerosis: benefits and risks.
Altered microRNA expression in B lymphocytes in multiple sclerosis: Towards a better understanding of treatment effects.
Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study.
Higher Relative Risk for Multiple Sclerosis in a Pediatric and Adolescent Diabetes Population: Analysis From DPV Data Base.
Pregnancy level of estrogen attenuates experimental autoimmune encephalomyelitis in both ovariectomized and pregnant C57BL/6 mice through expansion of Treg and Th2 cells.
Effect of met-enkephalin on chromosomal aberrations in the lymphocytes of the peripheral blood of patients with multiple sclerosis.
LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex.

Pages